Jonathan Rippentrop, MD
Urology · Cedar Rapids, IANPI 1609874171
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (41.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Intuitive Surgical at 50.0% of the total. Reporting peaked in 2019 at $5,923 and has fallen 60.9% since, to $2,318 in 2025. Among urology clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $71.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Teleflex LLC$3K
- Neotract Inc.$1K
- Procept Biorobotics Corporation$842
- 180 Medical, Inc.$443
- Johnson & Johnson$346
- plus $1K from 23 others
What the payments were for
- Travel & lodging$6,08042%
- Food & beverage$4,91034%
- Education$3,35623%
- Gifts$2121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 37 | $7,273 |
| Teleflex LLC | 22 | $2,746 |
| Neotract Inc. | 22 | $1,480 |
| Procept Biorobotics Corporation | 6 | $842 |
| 180 Medical, Inc. | 21 | $443 |
| Johnson & Johnson | 18 | $346 |
| Astellas Pharma US Inc | 5 | $265 |
| Pfizer | 27 | $238 |
| Dendreon Pharmaceuticals LLC | 4 | $101 |
| AbbVie | 5 | $101 |
| Boston Scientific | 2 | $99 |
| Axonics, Inc. | 4 | $83 |
| Merck | 4 | $75 |
| Bayer | 4 | $65 |
| Verity Pharmaceuticals Inc. | 3 | $56 |
| Endo Pharmaceuticals Inc. | 3 | $43 |
| Urogen Pharma, Inc. | 2 | $43 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $37 |
| Blue Earth Diagnostics | 2 | $35 |
| Coloplast | 2 | $33 |
| Cook Medical LLC | 2 | $29 |
| Progenics Pharmaceuticals, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Endo USA, Inc. | 1 | $15 |
| Telix Pharmaceuticals | 1 | $14 |
| Vertex | 1 | $14 |
| Myovant Sciences Inc. | 1 | $13 |
| Olympus America Inc. | 1 | $13 |
| Palette Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,608
- UroLift System$2,220
- UroLift$941
- AquaBeam Robotic System$739
How this compares
$14,557 in reported general payments places this provider in the 90th percentile of 114 urology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 40 | $555,798 |
| MyrbetriqMirabegron | 56 | $48,946 |
| Abiraterone Acetate | 24 | $13,449 |
| Tamsulosin Hcl | 680 | $9,044 |
| Solifenacin Succinate | 142 | $8,607 |
| Oxybutynin Chloride ErOxybutynin Chloride | 127 | $3,357 |
| Potassium Citrate ErPotassium Citrate | 35 | $3,098 |
| Trimethoprim | 48 | $2,902 |
| Finasteride | 216 | $2,256 |
| Testosterone | 16 | $1,326 |
| NitrofurantoinNitrofurantoin Macrocrystal | 29 | $1,086 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 48 | $970 |
| Tadalafil | 11 | $644 |
| Acetic Acid | 25 | $307 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 63 | $303 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $265 | $604,74496 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 114 urology providers in Iowa.
Other urology in Cedar Rapids
- Gregory JandaCedar Rapids$12K
- Michael MoriartyCedar Rapids$8K
- Steven MindrupCedar Rapids$8K
- Matthew FerroniCedar Rapids$5K
- Thomas RichardsonCedar Rapids$5K
- Vignesh PackiamIowa City$112K
- Annah VollstedtIowa City$66K
- Bradley EricksonIowa City$65K
- Michael OdonnellIowa City$62K
- Kevin BirusinghDes Moines$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.